Its overexpression in adipose tissues of aP2-SREBP-1c transgenic mice promotes insulin resistance and diabetes mellitus with an increased blood glucose level (>300 mg/dL) that failed to decrease even with insulin therapy. The gene discussed is SREBF1; the disease is Insulin resistance.